Correlation Between Iovance Biotherapeutics and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Werewolf Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Werewolf Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Werewolf Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Iovance and Werewolf is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Werewolf Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Werewolf Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.83 times less risky than Werewolf Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Werewolf Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 223.00 in Werewolf Therapeutics on September 17, 2024 and sell it today you would lose (56.00) from holding Werewolf Therapeutics or give up 25.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Iovance Biotherapeutics vs. Werewolf Therapeutics
Performance |
Timeline |
Iovance Biotherapeutics |
Werewolf Therapeutics |
Iovance Biotherapeutics and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and Werewolf Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |